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Abstract 
A developmentally regulated exon has been identified in the 5’-alternatively spliced region of the human fast Troponin T (TnT) gene. Expressed 
in fetal (but not adult) muscle, this exon is homologous with the fetal exons recently described in the rabbit and rat fast TnT genes. They all exhibit 
a split codon organization and encode a highly acidic peptide. To determine if the splicing pathways, including the human fetal exon, are also 
conserved, we defined the major TnT splicing patterns in fetal muscle. They generate fetal TnT 1, fetal TnT 3, and TnTlf, and TnT3f, species 
previously described in rabbit and rat skeletal muscles. 
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1. Introduction 
The heterogeneity of fast Troponin T’s (TnT) in verte- 
brate skeletal muscle is due largely to variation in their 
N-terminal amino acid sequences [l-3]. In adult fast 
skeletal muscle, the different N-terminal sequences arise 
from alternative splicing involving five 5’-exons which 
create a hypervariable region in the molecule [4]. A sixth 
exon that contributes to the N-terminal heterogeneity of 
TnT’s in fetal and early neonatal muscle was described 
recently in rabbit and rat skeletal muscles 15-71. This 
exon, designated the fetal exon F, shares several proper- 
ties with the other 5’-miniexons. They all exhibit the 
same split codon organization and similar purine-rich 
sequences. These sequences encode acidic peptides that 
account for the more acidic pIs of fetal TnT’s [8]. The 
developmentally regulated alternative splicing of the 
fetal exons, however, distinguishes them from the other 
5’-miniexons, which are expressed in both developing 
and adult muscles. In contrast, the fetal exon is included 
in the majority of late fetal TnT mRNAs, but its ability 
to be recognized as an exon is lost during neonatal devel- 
opment. The aims of this study were to determine 
whether a fetal exon is also present in human fetal muscle 
TnT mRNAs and to compare the alternative splicing of 
TnT mRNAs in human fetal muscle with those observed 
in rabbit and rat. 
2. Materials and methods 
2. I. Amplification and sequencing of the S-alternatively spliced regions 
of human fetal TnT 
Total RNA was prepared [9] from 12-13 week (X87-2) and 18 week 
(X87-l) fetal muscle samples kindly provided by John Gilbert of the 
Joseph and Kathleen Bryan Alzheimers Research Center at Duke 
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University Medical Center. Adult muscle RNA was provided by 
William Kraus at Duke University Medical Center. 
Reverse transcription-PCR with the thermostable enzyme rTth 
(Perkin Elmer-Cetus) was performed as described [6]. Primers that 
flanked the alternatively spliced 5’-region were selected from a full- 
length human fast TnT coding sequence [lo], using the MacVector 
primer pair subroutine. Their sequences are CCCACCTTCAC- 
CATGTCT and CGAAGTCCACTTTCTCCC. After 5 min reverse 
transcription at 70°C the buffer conditions were adjusted, and the PCR 
reactions denatured at 94°C for 2 min, and amplified using 25-35 cycles 
of 1 min at 94°C 30 s at 53”, and 1 min at 72°C. Products were cloned 
in the pCR II TA vector (Invitrogen), and 16 clones were sequenced 
using the Circumvent DNA sequencing kit (New England Biolabs). 
2.2. Analysis of TnT cDNAs by gel-electrophoresis 
rTth reactions were performed with a “P-endlabeled upstream 
primer, and the products were resolved with a 4% polyacrylamide/7 M
urea gel. Their sizes were determined by comparison with sequencing 
reactions run in adjacent lanes. The radiolabeled products were visual- 
ized with a Fujix phosphoimager, and quantified with the McBas pro- 
gram. 
Radiolabeled samples were prepared for restriction enzyme analysis 
by phenol/chloroform extraction and precipitation. Following diges- 
tion with Thai, which recognizes a site present only in the fetal exon, 
the samples were analyzed on a 4% gel as described above or by 
autoradiography. 
3. Results 
3.1. rTth amplification of the S-alternatively spliced 
region of human TnT mRNAs yields four major 
products 
Based on the sequence of a human fetal TnT cDNA 
[lo], primers spanning the 5’-alternatively spliced exons 
of fast TnT were used to generate cDNAs by reverse 
transcription-PCR with the thermostable nzyme rTth. 
Amplification of total RNA isolated from two fetal skel- 
etal muscle samples, X87-l and X87-2, generated cDNA 
products of 214, 190, 18 1, and 157 nucleotides (nt) (Fig. 
1). Previous studies indicated that this approach pro- 
vides a representative sample of the TnT RNA popula- 
tion [6], and is preferable to screening cDNA libraries for 
analyzing the 5’ alternative splicing patterns because 
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Fig. 1. Analysis of the RT-PCR products from human fetal muscle 
RNA. RNA prepared from two human fetal muscle samples, (a) X-87-l 
and (b) X-87-2, was amplified with rTth and TnT primers spanning the 
S-alternatively spliced region. A “P-endlabeled upstream primer was 
included in the PCR, and the resulting radiolabeled products were 
resolved by denaturing polyacrylamide gel electrophoresis and 
phosphoimaging. 
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most TnT clones isolated from cDNA libraries are not 
full-length ([4,11]; Briggs and Schachat, unpublished ob- 
servations). The mixture of cDNAs was cloned and their 
sequences were determined from at least two independ- 
ent rTth reactions. 
3.2. Identification of a 24 nt fetal exon in the human j&t 
Tn T gene 
Nucleotide sequences corresponding to the four major 
cDNA products were obtained (Fig. 2). Overall these 
sequences are quite similar to those of rat and rabbit 
cDNAs, and the translated amino acid sequences are 
nearly identical over much of the region (Fig. 3). Com- 
bining this sequence information with the exon organiza- 
tion of the rat fast TnT gene [12] allows several splicing 
patterns of the human cDNAs to be defined. The small- 
est major product at 157 nt contains exons 4, 5, and 8 
and thus corresponds to TnT3f, as previously defined in 
rabbit and rat TnT’s. The additional sequence in the 190 
product lies between exons 5 and 8. This sequence is 
homologous to that of exons 6 and 7; thus the 190 nt 
product most likely corresponds to TnTlf. The 214 and 
181 nt products exhibit the same exon combinations as 
TnTlf and TnT3f, but both contain an additional 24 nt 
sequence. This insert is located between exons 8 and 9, 
in the same position as the fetal sequences from rabbit 
[5,6] and rat [5-71. Thus, by analogy with the rabbit and 
rat fetal TnT’s, the 24 nt insert results from incorpora- 
tion of the fetal exon, and the 214 nt product encodes the 
VE EQ Y E E E EEAQEE 
all CCTTCACCATGTCTGACGAGGAAGTITGAACAGGTGGAGGIAGCAGTACGAAGAAGAAG(AGGAAGCCCAGGAGGAAG) 
RAT TnTlf CAGCCACTATGTCTGACGAGGAAAC)TGAACAAGTTGAGGIAACAGTACGAAGAGGAAGIAGGAGGCCCAGGAGGAAGI 
exon 213 3 14 415 51 
HUMAN AAEVHEE V H E P E EV Q E DTAEEDAE 
fetal TnTl (214) CTGCAGAAGTCCATGAGGAAGITTCATGAACCAG(AGGAAGTTC~G~GIACACCGCAGAGGAGGACGCGGAAG) 
TnTlf (190) +++++++++++++++++++++l++++++++++++l++++++++~++++++l------------------------l 
fetal TnT3 (181) -------_--_--_--___--l------------l +++++++++++++++I++++++++++++++++++++++++! 
TnT3f (157) -------_-----_---__--l------------l +++++++++++++++I_______________-__--_---I 
TnT3f* (142) -__-_--_-----____-___l____________l_____------~--~~_-__________--_--_---_--~ 
RAT TnTlf ------AAGTCCA~A~~~CScCccnncCplA~~GTCC~G~Gl------------------------I 
6 8 1 F(FETAL) (FETAL) F I 
EEKPRPK LTAPKIPEGEKVDF 
all AGGAGAAACCGAGACCCAAIACTCACTGCTCCTAAGATCCCAG~~G~GTGC9CTTCG 
RAT TnTlf AGGAGAAACCAAGACCCAAIACTTACTGCTCCTAAGATCCCGGAAGGAGAGAAAGTAGACTTCG 
9 9 1 10 
Fig. 2. Nucleic acid sequences of five human TnT cDNAs. The first four sequences correspond to the major cDNA products observed in Fig. I, The 
locations of the primers used in Fig. 1 are underlined. Identical sequences are indicated by (+), and the nucleotides absent from some sequences are 
indicated by (-). The rat TnT sequence and boundaries of exons 4, 5,6,7, 8, and 9 are taken from Breitbart [4,12], and that of fetal exon from Briggs 
and Schachat [6]. The presence or absence of homologous blocks of sequence was used to define the exon boundaries in the human sequences. Due 
to greater sequence divergence and the absence of different splicing patterns involving exons 6 and 7, their boundary was estimated by homology 
with the rat exons. 
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Exon 2 3 4 5 6 7 8 fetal 9 
HUm MSDEEV EQVE EQYEEE EEAQEE ---AAEVHEE ---VHEP EEVQE DTA-----EEDAE EEKPRPK 
Rat MSDEET EQVE EQYEEE EEAQEE -----EVQEE APE---P EEVQE DAVAEEEREEDEE EEKPRPK 
Rab MSDEEV EHVE EQYEEE EEAQEE APSPAEVHEP APEVHVP EEVHE DAL-EDMREEEEE EEKPRPK 
Fig. 3. Alignment of the predicted amino acid sequence of human fetal TnTl with rat and rabbit TnT’s. The translated N-terminal sequences of rat 
and rabbit TnT’s [4,lI,25] are augmented with the fetal exons of rat [5-71 and rabbit [5,6] TnT. 
N-terminal region of fetal TnT 1. Similarly, the 181 nt 
product arises from mRNAs specifying fetal TnT 3. Al- 
though the human fetal exon is considerably shorter than 
its rat and rabbit counterparts (24 vs. 39 and 36 nts, 
respectively), like them it encodes an acidic peptide 
(DTAEEDAE), exhibits a 1:2 split exon organization, 
and is the most distal of the 5’-miniexons in the fast 
troponin T gene. 
The four major cDNAs all represent exon combina- 
tions that are expressed in rabbit and rat muscles. A fifth 
cDNA, which has not been reported previously in fetal 
muscle, was also observed. It is labeled TnT3fr because 
it, like TnT3f, does not contain exons 6 and 7, but it also 
lacks exon 8. Based on densitometric analysis, this 
cDNA represents less than 1% of the total PCR prod- 
ucts. 
3.3. Evidence for the developmental speciJicity of the fetal 
exon 
To determine whether expression of the human fetal 
exon is specific for developing muscle, the 5’-alterna- 
tively spliced regions of TnT mRNAs were amplified 
from both fetal and adult skeletal muscle RNA (Fig. 4). 
Densitometric analysis showed that TnT’s containing the 
fetal exon (fetal TnTl and fetal TnT3) are 24 and 53% 
of the total in the fetal muscle samples X-87-l and X87-2, 
respectively (Figs. 1 and 4), but they comprise less than 
1% of the TnT in adult muscle RNA. To determine 
whether the fetal exon is present in the other TnT’s in 
adult muscle, the amplified products were digested with 
a restriction enzyme, Thai, that recognizes a unique site 
in these cDNA products, in the fetal exon (Fig. 4,a’,b’). 
Fetal TnTl and fetal TnT3 are cleaved in the fetal sam- 
ple, but none of the other bands in the adult sample is 
susceptible to Thai cleavage. Thus, like its rabbit and rat 
counterparts, the human fetal exon is not expressed at 
significant levels in adult skeletal muscles. 
4. Discussion 
The identification of a new, developmentally regulated 
exon in the rabbit and rat fast TnT genes [S-7] led us to 
investigate whether a similar exon is incorporated in 
human fetal skeletal muscle TnT mRNAs. Wu et al. [lo] 
isolated the first full-length human fetal cDNA clone. 
While it had many of the properties expected of fetal 
TnT’s, notably the expression of the 3’-exchangeon exon 
17, it appeared to lack a fetal exon. Given the difficulty 
in aligning a single N-terminal TnT cDNA due to repeat- 
ing sequence motifs, sequence divergence, and the multi- 
plicity of potential alternative splicing pathways, we took 
a direct approach to determining whether a fetal exon is 
expressed. In previous studies [5,6] we found that reverse 
transcription-PCR with rTth yields a representative sam- 
ple of the 5’-alternatively spliced sequences in rabbit 
muscle RNA. Sequence comparison showed that the re- 
sulting cDNAs were derived from several different alter- 
native splicing patterns, which allowed the miniexon 
boundaries of the rabbit fast TnT gene to be defined. 
Using this approach with human fetal muscle, we 
found four major rTth products, which can be divided 
into two pairs; the 214 and 190 cDNAs differ only by a 
a a’ b b’ 
fetal TnTl- 
TnTlf- 
fetal TnT3- 
TnT3f - 
Fig. 4. Comparison of fetal exon expression in fetal and adult muscle. 
The S-alternatively spliced TnT sequences present in fetal (X87-l) and 
adult muscle RNA (lanes a, b) were amplified by the rTth reaction using 
the same primers as in Fig. I. These cDNAs were digested by Thai 
(lanes a’, b’) and the cleavage products marked with an asterisk (*). The 
lack of change in the adult sample (b,b’) indicates that none of the 
additional bands in that sample contain the fetal exon. 
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24 nt insert, as do the 181 and 157 nt cDNAs. Since the 
214 and 18 1 nt cDNAs exhibit the same splicing patterns 
as fetal TnTl and fetal TnT3 in rabbit and rat skeletal 
muscle [1,6], the 24 nt insert is identified as the human 
fetal exon by its homology with the rabbit and rat fetal 
exons. First, it is expressed in fetal but not adult muscle. 
Second, although the human fetal exon is smaller than 
its homolog in rat and rabbit, it has a similar acidic 
character, split exon organization, and genomic location 
between exons 8 and 9. 
Because many 5’-alternatively spliced variants of 
mammalian fast TnT mRNAs have been postulated [4], 
but far fewer protein isoforms [l] or full-length cDNAs 
have been found [4,11], we analyzed the splicing patterns 
of the other human fetal TnT’s to determine whether new 
splicing patterns are utilized. Like the fetal TnT’s, the 
two other products observed, TnTlf and TnT3f, also 
correspond to isoforms identified in rat or rabbit fetal 
muscle. The remaining sequence (TnT3fk) is a new splic- 
ing pathway; although it is not easily detected among the 
fetal muscle PCR products, a band of the appropriate 
size (142 nt) makes up approximately 2% of the TnT 
cDNAs in the adult muscle sample. 
The acidic character of the peptide specified by the 
human fetal exon may be essential to both the function 
of the fetal TnT proteins and indirectly to recognition of 
the exon during the splicing process in fetal muscle. In 
rat and rabbit, expression of the fetal exon results in the 
insertion of nine and eight acidic residues, respectively, 
in the TnT protein. Similarly, expression of the human 
fetal exon results in the insertion of eight residues, five 
of which are acidic. Because variation in N-terminal se- 
quences appears to alter the calcium-sensitivity and re- 
sponsiveness of thin filaments [13], the insertion of a 
string of acidic residues may be related to the reduced 
calcium sensitivity of fetal muscle fibers [14,15]. The ex- 
pression of TnT3f at this stage of development is also 
consistent with the physiology of fetal muscle, as it is the 
least Ca’2-sensitive of the fast TnT’s, as measured in 
adult muscles [131. 
The indirect role of these acidic residues in enabling 
the fetal exon to be recognized during RNA processing 
relates to the sequences of their codons. Short exons, like 
the 24 nt fetal exon, generally are not efficiently spliced 
[16-181. In the case of the rat [6] and the rabbit (Maready 
and Schachat, unpublished observations), the splicing of 
the fetal exon is further negatively affected by the pres- 
ence of a suboptimal 3’ splice acceptor site in intron 8. 
In several genes, these negative factors are compensated 
for by the presence of a polypurine sequence in an exon 
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or its 3’ intron that allows it to be recognized and incor- 
porated into the spliced RNA [19-241. In the case of the 
human fetal exon, the codons for the glutamic and aspar- 
tic acid residues (GAA, GAG, GAC) provide a poly- 
purine tract that may be critical to the definition of the 
fetal exon and, in the presence of developmentally regu- 
lated trans-acting factors, enable it to be recognized as 
an exon in fetal muscle. 
Acknowledgements: This work was supported by National Institutes of 
Health grants AM 37344 and 39603 to F.S. 
References 
PI 
121 
[31 
141 
[51 
161 
[71 
F31 
[91 
UOI 
1111 
P21 
[I31 
u41 
t151 
[I61 
u71 
V81 
1191 
PO1 
1211 
m 
~231 
~241 
WI 
Briggs, M.M., Lin, J.J.C. and Schachat, F.H. (1987) J. Must. Res. 
Cell Motil. 8, I-12. 
Briggs, M.M. and Schachat, F. (1989) J. Mol. Biol. 206, 245-249. 
Wilkinson, J.M., Moir, A.J.G. and Waterfield, M.D. (1984) Eur. 
J. Biochem. 143,47-56. 
Breitbart, R.E., Nguyen, H.T., Medford, R.M., Mahdavi, V. and 
Nadal-Ginard, B. (1985) Cell 41, 67-82. 
Briggs, M.M. and Schachat, F. (1992) Mol. Biol. Cell 3, 256a. 
Briggs, M.M. and Schachat, F. (1993) Dev. Biol. 158, 503-509. 
Morgan, M.J., Earnshaw, J.C. and Dhoot, G.K. (I 993) J. Cell Sci. 
106, 9033908. 
Briggs, M.M., McGinnis, H.D. and Schachat, F. (1990) Dev. Biol. 
140, 2533260. 
Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156 
159. 
Wu, Q.-L. et al. (1994) DNA Cell Biol. 13, 217-233. 
Fujita, S., Maeda, K. and Maeda, Y. (1991) J. Must. Res. Cell 
Motil. 12, 560-565. 
Breitbart, R.E. and Nadal-Ginard, B. (1986) J. Mol. Biol. 188, 
313-324. 
Schachat, F.H., Diamond, MS. and Brandt, P.W. (1987) J. Mol. 
Biol. 198, 551-554. 
Sreter, F.A., Balint, M. and Gergely, J. (1975) Dev. Biol. 46, 
317-325. 
Pette, D., Vrbova, G. and Whalen, R.C. (1979) Pflug. Arch. 378, 
251-257. 
Sterner, D.A. and Berget, S.M. (1993) Mol. Cell. Biol. 13, 2677- 
2687. 
Black, D.L. (1991) Genes Dev. 5, 389402. 
Dominski, Z. and Kole, R. (1991) Mol. Cell. Biol. 11,607556083. 
Cooper, T. (1992) J. Biol. Chem. 267, 533c-5338. 
Xu, R., Teng, J. and Cooper, T.A. (1993) Mol. Cell. Biol. 13, 
3660-3674. 
Helfman, D.M., Ricci, W.M. and Finn, L.A. (1988) Genes Dev. 
2, 1627-1638. 
Mardon, H.J., Sevastio, G. and Barralle, F.E. (1987) Nucleic 
Acids Res. 15, 7725-7733. 
Katz, R.A. and Skalka, A.M. (1990) Mol. Cell. Bioi. 10, 696704. 
Watanabe, A., Tanaka, K. and Shimura, Y. (1993) Genes Dev. 7, 
407418. 
Pearlstone, J.R., Carpenter, M.R. and Smillie, L.B. (1977) J. Biol. 
Chem 252, 971-977. 
